Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
โ Scribed by Drescher, C. W.; Hawley, S.; Thorpe, J. D.; Marticke, S.; McIntosh, M.; Gambhir, S. S.; Urban, N.
- Book ID
- 115537447
- Publisher
- American Association for Cancer Research
- Year
- 2012
- Tongue
- English
- Weight
- 371 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1940-6207
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The costs and effects of different invitation schedules of breast cancer screening are compared. The effect estimates are based on trials from the USA, Sweden and the Netherlands. The cost estimates use registration data, file studies and organization charts. The calculations were performed with the
## BACKGROUND. Because the mortality rate from lung cancer is increasing sharply in Japan, lung cancer screening is being performed actively to assure early diagnosis and early treatment. However, its effectiveness is not clear, because it is extremely difficult to diagnose early microcarcinoma of
Cost-effectiveness analyses (CEAs) can help to quantify the contribution of the promotion of a screening program to increased participation in screening. The cost-effectiveness (C/E) of screening promotion depends in large part on the endpoints of interest. At the most fundamental level, the C/E of